NM_004092.4:c.89-160G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004092.4(ECHS1):​c.89-160G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.885 in 152,184 control chromosomes in the GnomAD database, including 60,482 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 60482 hom., cov: 32)

Consequence

ECHS1
NM_004092.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0340

Publications

14 publications found
Variant links:
Genes affected
ECHS1 (HGNC:3151): (enoyl-CoA hydratase, short chain 1) The protein encoded by this gene functions in the second step of the mitochondrial fatty acid beta-oxidation pathway. It catalyzes the hydration of 2-trans-enoyl-coenzyme A (CoA) intermediates to L-3-hydroxyacyl-CoAs. The gene product is a member of the hydratase/isomerase superfamily. It localizes to the mitochondrial matrix. Transcript variants utilizing alternative transcription initiation sites have been described in the literature. [provided by RefSeq, Jul 2008]
ECHS1 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-133370917-C-G is Benign according to our data. Variant chr10-133370917-C-G is described in ClinVar as [Benign]. Clinvar id is 683758.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ECHS1NM_004092.4 linkc.89-160G>C intron_variant Intron 1 of 7 ENST00000368547.4 NP_004083.3 P30084

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ECHS1ENST00000368547.4 linkc.89-160G>C intron_variant Intron 1 of 7 1 NM_004092.4 ENSP00000357535.3 P30084

Frequencies

GnomAD3 genomes
AF:
0.885
AC:
134606
AN:
152066
Hom.:
60454
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.710
Gnomad AMI
AF:
0.897
Gnomad AMR
AF:
0.939
Gnomad ASJ
AF:
0.923
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.943
Gnomad FIN
AF:
0.978
Gnomad MID
AF:
0.889
Gnomad NFE
AF:
0.949
Gnomad OTH
AF:
0.910
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.885
AC:
134683
AN:
152184
Hom.:
60482
Cov.:
32
AF XY:
0.889
AC XY:
66159
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.710
AC:
29439
AN:
41474
American (AMR)
AF:
0.939
AC:
14367
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.923
AC:
3203
AN:
3470
East Asian (EAS)
AF:
1.00
AC:
5176
AN:
5176
South Asian (SAS)
AF:
0.943
AC:
4550
AN:
4824
European-Finnish (FIN)
AF:
0.978
AC:
10372
AN:
10608
Middle Eastern (MID)
AF:
0.884
AC:
260
AN:
294
European-Non Finnish (NFE)
AF:
0.949
AC:
64574
AN:
68010
Other (OTH)
AF:
0.911
AC:
1924
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
702
1403
2105
2806
3508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.914
Hom.:
3166
Bravo
AF:
0.873
Asia WGS
AF:
0.965
AC:
3355
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.99
DANN
Benign
0.79
PhyloP100
0.034
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7894051; hg19: chr10-135184421; API